Semler Scientific (NASDAQ:SMLR - Get Free Report) posted its earnings results on Monday. The company reported $0.72 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.35, Zacks reports. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%. The business had revenue of $13.51 million for the quarter.
Semler Scientific Stock Performance
SMLR traded up $9.03 on Tuesday, hitting $39.00. The company had a trading volume of 769,217 shares, compared to its average volume of 189,260. The stock has a market capitalization of $272.61 million, a price-to-earnings ratio of 19.12 and a beta of 0.92. The stock has a fifty day moving average price of $25.92 and a 200-day moving average price of $28.63. Semler Scientific has a 12-month low of $20.88 and a 12-month high of $53.38.
Insider Buying and Selling
In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the business's stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now directly owns 60,220 shares in the company, valued at $1,707,237. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 30.20% of the stock is currently owned by company insiders.
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
